The Cyclin-Dependent Kinase Inhibitor p27 (Kip1) Regulates Both DNA Synthesis and Apoptosis in Mammary Epithelium but Is Not Required for Its Functional Development during Pregnancy

Molecular Endocrinology

Volumn 17, Issue 12, 2003, Pages 2436-2447

  Davison, Elizabeth A ^a   Lee, Christine S L ^a   Naylor, Matthew J ^a   Oakes, Samantha R ^a   Sutherland, Robert L ^a   Hennighausen, Lothar ^b   Ormandy, Christopher J ^a   Musgrove, Elizabeth A ^a,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DNA; KIP1 PROTEIN; PROTEIN P27; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; ENZYME INHIBITION; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL DIVISION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPITHELIAL CELLS; FEMALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; PREGNANCY; PREGNANCY, ANIMAL; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0347480264     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0199     Document Type: Article

References (45)

1. Slingerland J, Pagano M 2000 Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183:10-17
2. Chiarle R, Pagano M, Inghirami G 2001 The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. Breast Cancer Res 3:91-94
3. De Paolo F, Vecci AM, Granoto AM, Liverani M, Monti F, Innoceta AM, Gianni L, Saragoni L, Ricci M, Falcini F, Amadori D, Volpi A 2002 p27/Kip1 expression in normal epithelium, benign and neoplastic breast lesions. J Pathol 196:26-31
4. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ 1998 The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396:177-180
5. Philipp J, Vo K, Gurley KE, Seidel K, Kemp CJ 2001 Tumor suppression by p27/Kip1 and p21/Cip1 during chemically induced skin carcinogenesis. Oncogene 18: 4689-4698
6. Philipp-Staheli J, Kim K-H, Payne SR, Gurley KE, Liggitt D, Longton G, Kemp CJ 2002 Pathway-specific tumor suppression: reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 1:355-368
7. Kip1. Mol Endocrinol 11:1593-1607
8. Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM 2000 Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci USA 97:9042-9046
9. Carroll JS, Prall OW, Musgrove EA, Sutherland RL 2000 A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence. J Biol Chem 275:38221-38229
10. Swarbrick A, Lee CS, Sutherland RL, Musgrove EA 2000 Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells. Mol Cell Biol 20:2581-2591
11. Ciarallo S, Subramaniam V, Hung W, Lee JH, Kotchetkov R, Sandhu C, Milic A, Slingerland JM 2002 Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor β-mediated G(1) arrest. Mol Cell Biol 22: 2993-3002
12. Sherr CJ, Roberts JM 1999 CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 15:1501-1512
13. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E 1997 New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862
14. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ 1999 The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583
15. Geng Y, Yu Q, Sicinska E, Das M, Bronson RT, Sicinski P 2001 Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. Proc Natl Acad Sci USA 98:194-199
16. Tong W, Pollard JW 2001 Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice. Mol Cell Biol 21:1319-1328
17. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM 1996 A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85: 733-744
18. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Huffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732
19. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY 1996 Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720
20. Topper YJ, Freeman CS 1980 Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60:1049-1106
21. Hennighausen L, Robinson GW 1998 Think globally, act locally: the making of a mouse mammary gland. Genes Dev 12:449-455
22. Hennighausen L, Robinson GW 2001 Signaling pathways in mammary gland development. Dev Cell 1:467-475
23. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C 1995 Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9:2364-2372
24. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA 1995 Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630
25. Robinson GW, Wagner K-U, Hennighausen L 2001 Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene. Oncogene 20:7115-7119
26. Jiang Z, Zacksenhaus E 2002 Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. J Cell Biol 156:185-198
27. Muraoka RS, Lenferink AE, Simpson J, Brantley DM, Roebuck LR, Yakes FM, Arteaga CL 2001 Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function. J Cell Biol 153:917-932
28. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE 1992 RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877
29. Fantl V, Edwards PA, Steel JH, Vonderhaar BK, Dickson C 1999 Impaired mammary gland development in Cyl1(-/-) mice during pregnancy and lactation is epithelial cell autonomous. Dev Biol 212:1-11
30. Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li T, Weinberg RA, Sicinski P 1999 Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97:767-777
31. Tong W, Pollard JW 1999 Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E-and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol Cell Biol 19:2251-2264
32. Coats S, Whyte P, Fero ML, Lacy S, Chung G, Randel E, Firpo E, Roberts JM 1999 A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Curr Biol 9:163-173
33. Kip1 safeguards against inflammatory injury. Nat Med 4:575-580
34. Kip1. J Clin Invest 103:597-604
35. Masuda A, Osada H, Yatabe Y, Kozaki K, Tatematsu Y, Takahashi T, Hida T 2001 Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments. Am J Pathol 158:87-96
36. Kim SG, Kim SN, Jong HS, Kim NK, Hong SH, Kim SJ, Bang YJ 2001 Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-β1-induced apoptosis in human gastric cancer cells. Oncogene 20:1254-1265
37. Dyer MA, Capko CL 2001 p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations. J Neurosci 21:4259-4271
38. Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S, Reed JC, Rosen JC 1996 Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development 122:4013-4022
39. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS 2002 The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111: 29-40
40. Zhang P, Wong C, DePinho RA, Harper JW, Elledge SJ 1998 Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev 12:3162-3167
41. Edwards PA, Ward JL, Bradbury JM 1988 Alteration of morphogenesis by the v-myc oncogene in transplants of mammary gland. Oncogene 2:407-412
42. Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL 1998 Mechanisms of cyclin-dependent kinase inactivation by progestins. Mol Cell Biol 18:1812-1825
43. Musgrove EA, Lee CS, Cornish AL, Swarbrick A, Sutherland RL 1997 Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. Mol Endocrinol 11:54-66
44. Lewis MT, Ross S, Strickland PA, Sugnet CW, Jimenez E, Scott MP, Daniel CW 1999 Defects in mouse mammary gland development caused by conditional haploin-sufficiency of Patched-1. Development 126:5181-5193
45. Bradbury JM, Edwards PA, Niemeyer CC, Dale TC 1995 Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev Biol 170:5535-5563